Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
about
Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistanceAAV-mediated administration of myostatin pro-peptide mutant in adult Ldlr null mice reduces diet-induced hepatosteatosis and arteriosclerosisAgeing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASHPeroxisome proliferator-activated receptor-alpha gene level differently affects lipid metabolism and inflammation in apolipoprotein E2 knock-in micePPARα in Obesity: Sex Difference and Estrogen Involvement.Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats.Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release.A novel anti-inflammatory natural product from Sphaeranthus indicus inhibits expression of VCAM1 and ICAM1, and slows atherosclerosis progression independent of lipid changes.Muscle ring finger-3 protects against diabetic cardiomyopathy induced by a high fat diet.Reduction of Food Intake by Fenofibrate is Associated with Cholecystokinin Release in Long-Evans Tokushima Rats.Bilobetin ameliorates insulin resistance by PKA-mediated phosphorylation of PPARα in rats fed a high-fat diet(-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana, Prevents Diabetes and Hyperlipidemia by Regulation of Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in High-Fat-Fed Mice(-)-Epicatechin-3-O-β-D-allopyranoside from Davallia formosana prevents diabetes and dyslipidemia in streptozotocin-induced diabetic mice.Anticancer Properties of PPARalpha-Effects on Cellular Metabolism and Inflammation.Validation of the Antidiabetic and Hypolipidemic Effects of Hawthorn by Assessment of Gluconeogenesis and Lipogenesis Related Genes and AMP-Activated Protein Kinase Phosphorylation.Antcin K, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects via Glucose Transporter 4 and AMP-Activated Protein Kinase Phosphorylation in MusclesPPARs and the kidney in metabolic syndrome.Association of gene variants with lipid levels in response to fenofibrate is influenced by metabolic syndrome statusHyperlipidemia: a new therapeutic target for diabetic neuropathy.AMP-activated protein kinase: an emerging drug target to regulate imbalances in lipid and carbohydrate metabolism to treat cardio-metabolic diseasesMeta-review of protein network regulating obesity between validated obesity candidate genes in the white adipose tissue of high-fat diet-induced obese C57BL/6J mice.Potential approaches to ameliorate hepatic fat accumulation seen with MTP inhibition.The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges.Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance.Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat.Fenofibrate administration to arthritic rats increases adiponectin and leptin and prevents oxidative muscle wasting.Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice.High FFA levels related to microalbuminuria and uncoupling of VEGF-NO axis in obese rats.Different contribution of muscle and liver lipid metabolism to endurance capacity and obesity susceptibility of mice.Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.PPAR-α agonist elicits metabolically active brown adipocytes and weight loss in diet-induced obese mice.Ferulic acid improves lipid and glucose homeostasis in high-fat diet-induced obese mice.Differential actions of PPAR-α and PPAR-β/δ on beige adipocyte formation: A study in the subcutaneous white adipose tissue of obese male mice.Comparative Evaluation of Gemcabene and PPAR Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.Gemcabene, a First-in-Class Hypolipidemic Small Molecule in Clinical Development, Attenuates Osteoarthritis and Pain in Animal Models of Arthritis and Pain.Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of AtherosclerosisUncoupling Protein 2 in Cardiovascular Health and Disease
P2860
Q24648189-298AB416-DCDA-4E07-8764-BD6515C887D2Q27309898-5C72690A-7FD0-429E-B225-25914618B472Q30454451-0EBA7F3F-09DA-4D87-B017-979805E9E0CAQ30513404-58686436-2BF9-4392-AF06-3F5B7DBDC1E3Q34143769-44826D8E-7FC5-4037-81CF-FB8210C44A2CQ34401755-FD22CB6C-D4BF-48F7-A452-8F2FA4266C7FQ34656848-FA0F372C-503A-44BD-87E5-E1B7F0D1F439Q35711283-904A938A-A440-4A5A-9539-1982C7EEA9EEQ35716907-60941681-DB1E-411A-9ED5-1341F877BBB3Q36089785-C5ECDAE8-E8AE-47B9-B553-883FB3AFF030Q36176541-CCCFBA2A-E2E0-4C23-8E8A-53F839940EFDQ36247485-CACC13F7-961F-489D-9632-18D99EB33D70Q36319820-976C2C5E-584E-4C50-A7E1-5376B0C4F266Q36675898-1568FE7F-F5D9-46B5-9C1C-4E30564FBEC2Q36838286-753F6B14-1C23-41E7-BFA8-80F31EEF99D4Q36924205-B1DBE3FF-9D53-46CB-9DF3-C009205C20A2Q37072216-85DF289F-2E3D-43C8-A15E-41D7E444DB61Q37183071-16F6F955-FB27-42DB-8685-CBA9AAE4A3D9Q37659233-DA132F02-BD40-46CE-A856-E5A9EC20DBB7Q38026549-31ED3AC7-3F7E-4A48-B238-0EA85B5A15FCQ38185432-86248986-87CE-4A90-B773-4388D6E8059BQ38195808-68FE1A4C-2629-4224-80D0-1B4B09037455Q38273378-110D6803-DEEA-4DC9-91D8-FA8F532882A0Q39175937-E62EB228-7F83-4555-A4E7-0609092C06ECQ41084345-65E57C0F-6EC8-45A0-BFBD-F055DF85E542Q42153233-558908E1-DB87-4FEE-BE1E-FC361AC1E2AEQ42175229-4E06C46A-8792-4B4C-ADD4-07C4456A0170Q44808846-E122AE48-F1B0-4DB9-AD37-BE7371AE8DA9Q46170731-F2C4ACC7-97CC-4ACC-984C-69F0BB59FD1CQ47121147-5A19207D-B4EB-4DB9-9620-CEE2E36F5D16Q47388274-24975B42-C778-4F60-98B2-B23FC8DE6CACQ47970720-A4F96C26-1C21-4973-B77D-895DF34500ADQ48206129-0E88E080-7383-41F2-9991-84435842106FQ53832429-FC1D3609-F40C-45E6-BEF1-E9648BA4BC59Q55424979-EFD4A4D2-2B47-4798-B5CF-3EDA00FE90EEQ57113485-EFC6E89C-10EF-4F42-91BC-8635E89781A0Q58335880-6D0CF6C4-CC90-4558-86A3-C5D7E838AD87
P2860
Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Peroxisome proliferator-activa ...... n LDL receptor-deficient mice.
@en
Peroxisome proliferator-activa ...... n LDL receptor-deficient mice.
@nl
type
label
Peroxisome proliferator-activa ...... n LDL receptor-deficient mice.
@en
Peroxisome proliferator-activa ...... n LDL receptor-deficient mice.
@nl
prefLabel
Peroxisome proliferator-activa ...... n LDL receptor-deficient mice.
@en
Peroxisome proliferator-activa ...... n LDL receptor-deficient mice.
@nl
P2093
P1476
Peroxisome proliferator-activa ...... n LDL receptor-deficient mice.
@en
P2093
Charles L Bisgaier
Rai Ajit K Srivastava
Ravi Jahagirdar
Salman Azhar
Somesh Sharma
P2888
P356
10.1007/S11010-005-9053-Y
P577
2006-02-14T00:00:00Z